Nova Patents
CA2752046C

Copolymers for intraocular lens systems

Abstract

Some embodiments provide a copolymer comprising: an acrylate recurring unit and an optionally substituted vinylaryl recurring unit, wherein a portion of at least one of the recurring units comprises a vinyl-dialkylsiloxy pendant group. The copolymers may be useful as soft acrylic haptics for intraocular lenses. Some embodiments further relate to intraocular lenses having a hydrophobic soft acrylic optic and a silicone haptic, such as a dual optic accommodative lens a having hydrophobic soft acrylic anterior and posterior optic bodies and a silicone haptic. Related copolymeric composite materials as well as additional embodiments of intraocular lenses, are also described herein.

CA2752046C, drawing sheet 1
Sheet 1 of 49

Term

3.4 yearsleft in the term

Expires 11 February 2030.

  1. Priority
  2. Filed
  3. Granted
  4. Today
  5. Expires

43 claims: 28 independent, 15 dependent

  1. 1
    CA 02752046 2016-11-18 What is claimed is:1. An intraocular lens comprising: an optic body comprising a first hydrophobic soft acrylic copolymer;and a haptic comprising a first silicone connected to the optic body;wherein the first hydrophobic soft acrylic copolymer comprises: an acrylate recurring unit;and an optionally substituted vinylaryl recurring unit;wherein a portion of at least one of the recurring units comprises a vinyldialkylsiloxy pendant group, and further wherein the first hydrophobic soft acrylic copolymer is prepared by a process comprising reacting monomer la, monomer 2, and monomer 3a;and monomer 4 or monomer 5a;wherein monomer la represents 20% to 70% of the total weight of all monomers present in the process and is represented by a formula: O' O' monomer 2 represents 10% to 40% of the total weight of all monomers present in the process and is represented by a formula: -53CA 02752046 2016-11-18 monomer 3a represents 5% to 40% of the total weight of all monomers present in the process and is represented by a formula: Ph 1 monomer 4 represents 1% to 20% of the total weight of all monomers present in the process and is represented by a formula: cr ο Si Ysi / \ / \ R- R ·’ R s R 5 , and monomer 5a represents 1% to 20% of the total weight of all monomers present in the process and is represented by a formula: Ph 2 / \ / \ R 4 R 4 R 6 R 6 R 1 and R 2 are independently C1-12 alkyl or optionally substituted phenyl;X is C1-4 alkyl;Y 1 , Y 2 , and Y 3 are independently H or C1-4 alkyl;-54CA 02752046 2016-11-18 Ph 1 and Ph 2 are independently optionally substituted phenyl;each R 3 and each R 4 is independently C1-4 alkyl or / \ r 5 r? each R 5 and each R 6 is independently C1-4 alkyl;R 7 is a covalent bond or C1-6 alkyl;and R 8 is C1-6 alkyl.
  2. 8
    A copolymer comprising:an acrylate recurring unit;and an optionally substituted vinylaryl recurring unit;wherein a portion of at least one of the recurring units comprises a vinyldialkylsiloxy pendant group, and further wherein the copolymer is prepared by a process comprising reacting monomer la, monomer 2, and monomer 3a;and monomer 4 or monomer 5 a;wherein monomer la represents 20% to 70% of the total weight of all monomers present in the process and is represented by a formula: -56CA 02752046 2016-11-18 / Rl ( ο monomer 2 represents 10% to 40% of the total weight of all monomers present in the process and is represented by a formula: R 2 monomer 3 a represents 5% to 40% of the total weight of all monomers present in the process and is represented by a formula: Ph 1 monomer 4 represents 1% to 20% of the total weight of all monomers present in the process and is represented by a formula: yo' / \ / \ R- R 5 R 5 R 5 -57CA 02752046 2016-11-18 and monomer 5a represents 1% to 20% of the total weight of all monomers present in the process and is represented by a formula: Ph* R -s ° R 4 \ 4 / \ R 6 R 6 R 1 and R 2 are independently C1-12 alkyl or optionally substituted phenyl;X is Cm alkyl;Y 1 , Y 2 , and Y 3 are independently H or Cm alkyl;Ph 1 and Ph 2 are independently optionally substituted phenyl;each R 3 and each R 4 is independently Cm alkyl or and each R 5 and each R 6 is independently Cm alkyl;R 7 is a covalent bond or C1-6 alkyl;and R 8 is C1-6 alkyl.
  3. 11
    A copolymer comprising:an acrylate recurring unit;and an optionally substituted vinylaryl recurring unit;wherein a portion of at least one of the recurring units comprises a vinyldialkylsiloxy pendant group, wherein the copolymer comprises the following recurring units: () Ph 1 Plr Si Si / \ / \ R 3 R 3 R 5 R 5 / \ / \ R 3 R 3 R 5 R 5 R 1 and R 2 are independently C1-12 alkyl or optionally substituted phenyl;-61CA 02752046 2016-11-18 X is Cm alkyl;Y 1 , Y 2 , and Y 3 are independently H or Cm alkyl;Ph 1 and Ph 2 are independently optionally substituted phenyl;each R 3 and each R 4 is independently Cm alkyl or each R 5 and each R 6 is independently Cm alkyl;R 7 is a covalent bond or Ci-6 alkyl;and R 8 is Ci-6 alkyl.
  4. 12
    A copolymer comprising :an acrylate recurring unit;and an optionally substituted vinylaryl recurring unit;wherein a portion of at least one of the recurring units comprises a vinyldialkylsiloxy pendant group, wherein the copolymer is prepared by a process comprising: reacting: monomer la, monomer 2, and monomer 3a;and monomer 4 or monomer 5 a;wherein monomer la is represented by a formula: -62CA 02752046 2016-11-18 and R* monomer 2, is represented by a formula: / r2 Ci o monomer 3a is represented by a formula: ’I monomer 4 is represented by a formula: y/ \ / \ R’ R 3 R 5 R 5 monomer 5 a represented by a formula: -63CA 02752046 2016-11-18 Ph 2 R. ^Si / \ R 4 R 4 R 6 R 6 R 1 and R 2 are independently Ci-6 alkyl;X is methyl or ethyl;Y 1 , Y 2 , and Y 3 are independently hydrogen or methyl;Ph 1 and Ph 2 are unsubstituted phenyl;each R 3 and each R 4 is independently vinyldimethylsiloxy or methyl;each R 5 and each R 6 is independently methyl or ethyl;R 7 is —CH2—, or —CH2CH2—;and R 8 is — (CH 2 )3—or —(CH 2 ) 4 —·
  5. 13
    An intraocular lens comprising a copolymeric composite material comprising:a silicone component, and an acrylic component;wherein the acrylic component comprises: an acrylate recurring unit;and an optionally substituted vinylaryl recurring unit;wherein a portion of said acrylate recurring units and optionally substituted vinylaryl recurring units comprise a vinyldialkylsiloxy pendant group;and -64CA 02752046 2016-11-18 wherein said copolymeric composite material comprises a plurality of siliconcarbon covalent bonds between a silicon atom of the silicone component and a carbon atom of a vinyldialkylsiloxy pendant group, and further wherein said silicon-carbon covalent bonds are created via a hydrosilylation reaction between said vinyldialkylsiloxy pendant group on at least one of the acrylate recurring units and an Si—H group of the silicone component;wherein the acrylic component comprises the following recurring units: or / \ / \ R 4 R 4 R 6 R 6 wherein R 1 and R 2 are independently C1-12 alkyl or optionally substituted phenyl;X is Ci-4 alkyl;Y 1 , Y 2 , and Y 3 are independently H or C1-4 alkyl;Ph 1 and Ph 2 are independently optionally substituted phenyl;each R 3 and each R 4 is independently C1-4 alkyl or -65CA 02752046 2016-11-18 / \ R 5 R 3 each R 5 and each R 6 is independently, Cm alkyl;R 7 is a covalent bond or Ci-6 alkyl;and R 8 is Ci-6 alkyl.
  6. 17
    The intraocular lens of any one of claims 14 to 16, wherein R 1 of the acrylic component is n-butyl.
  7. 18
    The intraocular lens of any one of claims 14 to 17, wherein R 2 of the acrylic component is ethyl and X of the acrylate component is methyl.
  8. 19
    The intraocular lens of any one of claims 14 to 18, wherein each R 3 of the acrylic component is vinyldimethylsiloxy or methyl.
  9. 20
    The intraocular lens of any one of claims 14 to 19, wherein each R 4 of the acrylic component is vinyldimethylsiloxy or methyl.
  10. 21
    The intraocular lens of any one of claims 14 to 20, wherein each R 5 of the acrylic component is methyl.
  11. 22
    The intraocular lens of any one of claims 14 to 21, wherein each R 6 of the acrylic component is methyl.
  12. 23
    The intraocular lens of any one of claims 14 to 22, wherein R 7 of the acrylic component is —CH 2 —, —CH 2 CH 2 —, or —CH 2 CH 2 CH 2 —.
  13. 24
    The intraocular lens of any one of claims 14 to 23, wherein R 8 of the acrylic component is —(CH 2 )3— or —(CH 2 )4—.
  14. 25
    The intraocular lens of any one of claims 14 to 24, wherein X of the acrylic component is methyl.
  15. 26
    The intraocular lens of any one of claims 14 to 25, wherein Y 1 of the acrylic component is hydrogen or methyl.
  16. 27
    The intraocular lens of any one of claims 14 to 26, wherein Y 2 of the acrylic component is hydrogen or methyl. -67CA 02752046 2016-11-18
  17. 28
    The intraocular lens of any one of claims 14 to 27, wherein Y 3 of the acrylic component is hydrogen or methyl.
  18. 29
    The intraocular lens of any one of claims 14 to 28, wherein Ph 1 of the acrylic component is unsubstituted phenyl.
  19. 30
    The intraocular lens of any one of claims 14 to 29, wherein Ph 2 of the acrylic component is unsubstituted phenyl.
  20. 31
    The intraocular lens of any one of claims 14 to 30, wherein the acrylic component is a copolymer prepared by a process comprising:reacting: monomer la, monomer 2, and monomer 3a;and monomer 4 or monomer 5 a;wherein monomer la is represented by a formula: monomer 2 is represented by a formula: monomer 3a is represented by a formula: -68CA 02752046 2016-11-18 monomer 4 is represented by a formula: Y 2 and / \ R J R ( / \ R 5 R s monomer 5a represented by a formula: h 2 / \ / \ R 4 R 4 R 6 R 6 R 1 and R 2 are independently C1-12 alkyl or optionally substituted phenyl;X is C1-4 alkyl;Y 1 , Y 2 , and Y 3 are independently H or Cm alkyl;Ph 1 and Ph 2 are independently optionally substituted phenyl;each R 3 and each R 4 is independently C1-4 alkyl or / \ R s R s each R 5 and each R 6 is independently Cm alkyl;-69CA 02752046 2016-11-18 R 7 is a covalent bond or Ci-6 alkyl;and R 8 is Ci-6 alkyl.
  21. 36
    The intraocular lens of any one of claims 31 to 35, further comprising reacting ethylene glycol dimethacrylate at any point in the process.
  22. 37
    The intraocular lens of any one of claims 31 to 36, further comprising reacting 2[3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl]ethyl methacrylate at any point in the process.
  23. 38
    The intraocular lens of any one of claims 31 to 37, wherein the process comprises a radical process initiated by 2,2'-azobisisobutyronitrile.
  24. 39
    The intraocular lens of any one of claims 31 to 38, wherein monomer 1 a represents 40% to 55% of the total weight of all monomers present in the process.
  25. 40
    The intraocular lens of any one of claims 31 to 39, wherein monomer 2 represents 15% to 25% of the total weight of all monomers present in the process.
  26. 41
    The intraocular lens of any one of claims 31 to 40, wherein monomer 3a represents 15% to 20% of the total weight of all monomers present in the process.
  27. 42
    The intraocular lens of any one of claims 31 to 41, wherein monomer 4 represents 2% to 20% of the total weight of all monomers present in the process.
  28. 43
    The intraocular lens of any one of claims 31 to 42, wherein the plurality of silicon-carbon covalent bonds comprise a covalent bond between an R 9 and a Z 1 or an R 10 and a Z 2 in a plurality of recurring units represented by a formula:-70CA 02752046 2016-11-18 wherein Y is H or C1-4 alkyl;Ph 2 is optionally substituted phenyl;each R 3 and each R 4 is independently C1-4 alkyl or / \ R 5 R 5 and each R 5 and each R 6 is independently C1-4 alkyl;R 7 is a covalent bond or C1-6 alkyl;and R 8 is Ci-6 alkyl;R 9 and R 10 are C2H4;and Z 1 and Z 2 are each a Si atom from an H—Si moiety of the silicone component wherein the H atom has been replaced with R 9 or R 10 .
Independent claims28